Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 7, 2015; 21(13): 3944-3952
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3944
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3944
Table 4 Lymph node metastasis in papillary adenocarcinoma-type early gastric cancers according to the current endoscopic submucosal dissection indication criteria n (%)
| Mucosal cancer (n = 14) | Submucosal cancer (n = 35) | ||||||
| Ulcer (-) (n = 10) | Ulcer (+) (n = 4) | sm1 (n = 8) | sm2 (n = 27) | ||||
| ≤20 mm | > 20 mm | ≤30 mm | > 30 mm | ≤30 mm | > 30 mm | Any size | |
| (n = 6) | (n = 4) | (n = 2) | (n = 2) | (n = 5) | (n = 3) | (n = 27) | |
| Lymph node metastasis | 0 (0) | 1 (25) | 0 (0) | 0 (0) | 1 (20) | 0 (0) | 7 (26) |
- Citation: Lee HJ, Kim GH, Park DY, Lee BE, Jeon HK, Jhi JH, Song GA. Is endoscopic submucosal dissection safe for papillary adenocarcinoma of the stomach? World J Gastroenterol 2015; 21(13): 3944-3952
- URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3944.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i13.3944